The Federal Trade Commission (FTC) has filed a lawsuit against the nation's three largest pharmacy benefit managers (PBMs) — Optum Rx, CVS Health's Caremark, and Express Scripts — alleging that their unfair practices contribute to inflated insulin prices. The FTC claims PBMs manipulate the pharmaceutical supply chain to increase drug costs, despite offering rebates that ostensibly lower patient copays.
The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers , claiming unfair practices inflated the cost of insulin.Pharmacy benefit managers, or PBMs, negotiate rebates on drugs for insurance companies, unions and government agencies. Those rebates help lower copay costs for patients, but critics say they also force manufacturers to increase the list price of a drug, ultimately raising the price for patients at the counter.
RELATED STORY | Walgreens settles allegations it submitted false payment claims for prescriptionsScripps News reached out to the PBMs listed in the lawsuit for a response. All three suggested the FTCs complaint presented a flawed view of the drug pricing process, and placed blame for the high costs of insulin elsewhere.
Pharmacy Benefit Managers Insulin Prices FTC Lawsuit Drug Pricing Healthcare Costs
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FTC sues drug middlemen for allegedly inflating insulin pricesThe FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group’s Optum Rx, CVS Health’s Caremark and Cigna’s…
Read more »
FTC sues top three pharmacy middlemen over insulin pricesPolitical News and Conservative Analysis About Congress, the President, and the Federal Government
Read more »
FTC Sues Pharmacy Benefit Managers Over Inflated Insulin PricesThe Federal Trade Commission (FTC) has filed a lawsuit against three major pharmacy benefit managers (PBMs) – Optum Rx, Caremark, and Express Scripts – alleging that they artificially inflate insulin prices to boost profits.
Read more »
FTC sues pharmaceutical middlemen, claiming practices inflated insulin costYou'll find Jason fishing for smart interviews, digging for the heart of the story and spelling out how the news shapes what happens next.
Read more »
FTC Sues Big Pharma Middlemen for Inflating Insulin PricesJessica Corbett is a senior editor and staff writer for Common Dreams.
Read more »
Shaboozey Sues Record Company For Breach Of ContractShaboozey sues record company for breach of contract.
Read more »